МУЖСКОЕ БЕСПЛОДИЕ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ


Цитировать

Полный текст

Аннотация

Не менее чем в половине случаев бесплодие пары связано с нарушениями сперматогенеза. Наиболее частыми причинами развития мужского бесплодия являются варикоцеле, воспалительные заболевания половой системы, гормональные нарушения и крипторхизм. В значительном числе случаев установить причину мужского бесплодия не удается. На сегодняшний день общепризнанных методов медикаментозного лечения идиопатической формы мужского бесплодия не существует и достаточно часто его терапия носит эмпирический характер. Вспомогательные репродуктивные технологии являются высокоэффективными методами лечения бесплодия, но характеризуются высокой стоимостью и инвазивностью.

Об авторах

С И Гамидов

Кафедра урологии ГОУ ВПО РГМУ им. Н.И. Пирогова Росздрава, Москва

Кафедра урологии ГОУ ВПО РГМУ им. Н.И. Пирогова Росздрава, Москва

В В Иремашвили

Кафедра урологии ГОУ ВПО РГМУ им. Н.И. Пирогова Росздрава, Москва

Кафедра урологии ГОУ ВПО РГМУ им. Н.И. Пирогова Росздрава, Москва

Р А Тхагапсоева

Кафедра урологии ГОУ ВПО РГМУ им. Н.И. Пирогова Росздрава, Москва

Кафедра урологии ГОУ ВПО РГМУ им. Н.И. Пирогова Росздрава, Москва

S I Gamidov

V V Iremashvili

R A Tchagapsoeva

Список литературы

  1. Wong WY, Thomas CMG, Merkus JM, et al. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril 2000;73:435-42.
  2. Жиборев БН. Заболевания органов половой системы в патогенезе нарушений репродуктивного здоровья мужчины // Урология. 2008. № 3. С. 62-67.
  3. Siddiq FM, Sigman M. A new look at the medical management of infertility. Urol Clin North Am 2002;29:949-63.
  4. Verstoppen GR, Steeno OP. Varicocele and the pathogenesis of the associated subfertility: a review of the various theories. II. Results of surgery. Andrologia 1977;9:293-305.
  5. World Health Organization. The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. Fertil Steril 1992;57:1289-93.
  6. Evers JLH, Collins JA. Assessment of efficacy of varicocele repair for male subfertility: a systematic review. Lancet 2003;361:1849-52.
  7. Laven JS, Haans LC, Mali WP, et al. Effects of varicocele treatment in adolescents: a randomised study. Fertil Steril 1992;58:756-62.
  8. Ness RB, Markovic N, Carlson CL, et al. Do men become infertile after having sexually transmitted urethritis? An epidemiologic examination. Fertil Steril. 1997;68:205-13.
  9. Cunningham KA, Beagley KW. Male genital tract chlamydial infection: implications for pathology and infertility. Biol Reprod 2008;79:180-89.
  10. Mieusset R, Bujan L, Massat G, et al. Clinical and biological characteristics of infertile men with a history of cryptorchidism. Hum Reprod 1995;10:613-19.
  11. Sadeghi-Nejad H <http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Sadeghi-Nejad%20H%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>, Oates RD <http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Oates%20RD%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>. The Y chromosome and male infertility. Curr Opin Urol 2008;18:628-32.
  12. Cavallini G. Male idiopathic oligoasthenoteratozoospermia. Asian J Androl 2006;8:143-57.
  13. Ochendorf FR. Infections in the male genital tract and reactive oxygen species. Hum Reprod Update 1999;5:399-420.
  14. Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction 2001;122:497-506.
  15. McLachlan RI, Wreford NG, O'Donnel L, et al. The endocrine regulation of spermatogenesis: independent roles for testosterone and FSH. J Endocrinol 1996;148:1-9.
  16. Sanocka D, Kurpisz M. Reactive oxygen species and sperm cells. Reprod Biol Endocrinol 2004;2:12-19.
  17. Sinha Hikim AP, Swerdloff RS. Hormonal and genetic control of germ cells apoptosis in the testis. Rev Reprod 1999;4:38-47.
  18. Said TM, Paasch U, Glander HJ, et al. Role of capases in male infertility. Hum Reprod Update 2004;10:39-51.
  19. Shang XJ, Huang YF, Xiong CL, et al. Uraplasma urealyticum infection and apoptosis of spermatogenetic cells. Asian J Androl 1999;1:127-29.
  20. Chiu WW, Chamley LW. Use of antisperm antibodies in differential display Western blotting to identify sperm proteins important in fertility. Hum Reprod 2002;17:984-89.
  21. Bohring C, Krause W. Immune infertility: towards a better understanding of sperm (auto)-immunity. The value of proteomic analysis. Hum Reprod 2003;18:915-24.
  22. Koide SS, Wang L, Kamada M. Antisperm antibodies associated with infertility: properties and encoding genes of target antigens. Proc Soc Exp Biol Med 2000;224:123-32.
  23. World Health Organization. Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 3rd ed. New York: Cambridge University Press 1993:43-44.
  24. Ombelet W, Bosmans E, Janssen M, et al. Semen parameters in a fertile versus subfertile population: a need for change in the interpretation of semen testing. Hum Reprod 1997;12:987-93.
  25. Purvis K, Christiansen E. Male infertility: current concepts. Ann Med 1992;24:259-72.
  26. Kruger TF, Acosta AA, Simmons KF, et al. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 1988;49:112-17.
  27. Evers JL, Collins JA. Surgery or embolisation for varicocele in subfertile men. Cochrane Database Syst Rev 2004;(3):CD000479.
  28. Ficarro V, Cerruto MA, Liguori G, et al. Treatment of varicocele in subfertile men: the Cochrane review - a contrary opinion. Eur Urol 2006;29:258-63.
  29. Kumar R, Gautam G, Gupta MP. Drug Therapy for Idiopathic Male Infertility: Rationale Versus Evidence. J Urol. 2006;176:1307-12.
  30. Vandekerckhove P, Lilford R, Vail A, et al. Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2000;2:CD000150.
  31. Chehval MJ, Mehan DJ. Chorionic gonadotropins in the treatment of the subfertile male. Fertil Steril 1979;31:666-68.
  32. Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2000;2:CD000151.
  33. Ochsendorf FR, Buhl R, Bastlein A, et al. Glutathione in spermatozoa and seminal plasma of infertile men. Hum Reprod 1998;13:353-59.
  34. Lenzi A, Culasso F, Gandini L, et al. Placebo-controlled, double blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod 1993;8:1657-62.
  35. Kessopoulou E, Powers HJ, Sharma KK, et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 1995;64:825-31.
  36. Rolf C, Cooper TG, Yeung CH, et al. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, doubleblind study. Hum Reprod 1999;14:1028-33.
  37. Lenzi A, Sgro P, Salacone P, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004; 81: 1578-1574.
  38. Gregoriou O, Vitoratos N, Papadias C, et al. Treatment of idiopathic oligozoospermia with an alpha-blocker: a placebo-controlled double-blind trial. Int J Fertil Womens Med 1997;42:301-05.
  39. Palermo G, Alikani M, Bertoli M, et al. Oolemma characteristics in relation to survival and fertilization patterns of oocytes treated by intracytoplasmic sperm injection. Human Reproduction 1996;11:172-76.
  40. Tarlatzis BC, Bili H. Intracytoplasmic sperm injection. Survey of world results. Annals of the New York Academy of Sciences 2000;900:336-44.
  41. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2303&mid=1085056570&magid=173

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2009